Development of acromegaly in patients with prolactinomas

European Journal of Endocrinology

Volumn 149, Issue 1, 2003, Pages 17-22

  Andersen, Marianne ^b   Hagen, Casper ^b   Frystyk, Jan ^a   Daa Schroeder, Henrik ^b   Hagen, Claus ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROLACTIN; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTINOMA; SCREENING TEST; SEX DIFFERENCE;

EID: 0037811288     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490017     Document Type: Article

References (26)

1. Lamberts SW, Liuzzi A, Chiodini PG, Verde S, Klijn JG & Birkenhager JC. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly. European Journal of Clinical Investigation 1982 12 151-155.
2. Functional Endocrine Pathology, vol. 1. Eds K Kovacs & SL Asa. Oxford: Blackwell Scientific Publications, 1991.
3. Mulcahy SS & Jaffe RB. Detection of a potential progenitor cell in the human fetal pituitary that secretes both growth hormone and prolactin. Journal of Clinical Endocrinology and Metabolism 1988 66 24-32.
4. Lloyd RV, Anagnostou D, Cano M, Barkan AL & Chandler WF. Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry. Journal of Clinical Endocrinology and Metabolism 1988 66 1103-1110.
5. Bassetti M, Spada A, Arosio M, Vallar L, Brina M & Giannattasio G. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule. Journal of Clinical Endocrinology and Metabolism 1986 62 1093-1100.
6. Lloyd RV, Cano M, Chandler WF, Barkan AL, Horvath E & Kovacs K. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization. American Journal of Pathology 1989 134 605-613.
7. Andersen M, Hansen TB, Bollerslev J, Bjerre P, Schrøder HD & Hagen C. Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study. Journal of Endocrinological Investigation 1995 18 840-846.
8. Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ & Liuzzi A. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly. Acta Endocrinologica 1983 103 446-450.
9. Peacey SR & Shalet SM. Insulin-like growth factor I measurement in diagnosis and management of acromegaly. Annals of Clinical Biochemistry 2001 38 297-303.
10. Daughaday WH & Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Reviews 1989 10 68-91.
11. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529.
12. Yamada S, Aiba T, Sano T, Kovacs K, Shishiba Y, Sawano S et al. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 1993 33 20-27.
13. Felig P, Baxter JD & Frohman LA. In Endocrinology and Metabolism, edn 3. Eds P Felig, JD Baxter & LA Frohman. New York: McGraw-Hill Inc., 1995.
14. de Herder WW, van der Lely AJ, Janssen JA, Uitterlinden P, Hofland LJ & Lamberts SW. IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly. Clinical Endocrinology 1995 43 501-505.
15. Ho KY & Weissberger AJ. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clinical Endocrinology 1994 41 75-83.
16. Stoffel-Wagner B, Springer W, Bidlingmaier F & Klingmuller D. A comparison of different methods for diagnosing acromegaly. Clinical Endocrinology 1997 46 531-537.
17. Peacey SR, Toogood AA, Veldhuis JD, Thorner MO & Shalet SM. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. Journal of Clinical Endocrinology and Metabolism 2001 86 259-266.
18. Asa SL, Kovacs K, Horvath E, Singer W & Smyth HS. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line. Journal of Clinical Endocrinology and Metabolism 1992 75 68-75.
19. Feigenbaum SL, Downey DE, Wilson CB & Jaffe RB. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up. Journal of Clinical Endocrinology and Metabolism 1996 81 1711-1719.
20. Bengtsson BA, Eden S, Ernest I, Oden A & Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica 1988 223 327-335.
21. Badawy SZA, Anderson GH, Shende MC & Marshall L. Development of acromegaly in a patient with prolactinemia: a case study. Fertility and Sterility 1984 42 926-928.
22. Bacsy E, Fazekas I, Slowik F, Pasztor E & Czirjak S. Transformation of a human mixed GH-PRL adenoma cell population in response to long-term bromocriptine treatment. Folia Histochemica Cytobiologica 1997 35 69-74.
23. Page MD, Bridges LR, Barth JH, McNichol AM & Belchetz PE. Development of acromegaly during treatment of hyperprolactinaemia with bromocriptine: an unusual acidophil stem cell adenoma. Journal of Clinical Endocrinology and Metabolism 1996 81 4484-4487.
24. Pagesy P, Li JY, Kujas M, Peillon F, Delalande O, Visot A et al. Apparently silent somatotroph adenomas. Pathology, Research and Practice 1991 187 950-956.
25. Yamada S, Sano T, Stefaneanu L, Kovacs K, Aiba T, Sawano S et al. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. Journal of Clinical Endocrinology and Metabolism 1993 76 352-356.
26. Torring O, Isberg B, Sjoberg HE, Bucht E & Hulting AL. Plasma calcitonin IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment. Acta Endocrinologica 1993 128 423-427.